- Home
- CRMD vs GLAD Comparison
CRMD vs GLAD Comparison
Compare CRMD & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- GLAD
- Stock Information
- Founded
- CRMD 2006
- GLAD 2001
- Country
- CRMD United States
- GLAD United States
- Employees
- CRMD N/A
- GLAD N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- GLAD Finance/Investors Services
- Sector
- CRMD Health Care
- GLAD Finance
- Exchange
- CRMD Nasdaq
- GLAD Nasdaq
- Market Cap
- CRMD 645.0M
- GLAD 644.5M
- IPO Year
- CRMD 2010
- GLAD N/A
- Fundamental
- Price
- CRMD $6.06
- GLAD $27.72
- Analyst Decision
- CRMD Strong Buy
- GLAD Hold
- Analyst Count
- CRMD 7
- GLAD 1
- Target Price
- CRMD $15.14
- GLAD $23.00
- AVG Volume (30 Days)
- CRMD 2.0M
- GLAD 90.5K
- Earning Date
- CRMD 03-25-2025
- GLAD 04-30-2025
- Dividend Yield
- CRMD N/A
- GLAD 8.64%
- EPS Growth
- CRMD N/A
- GLAD 60.05
- EPS
- CRMD N/A
- GLAD 4.63
- Revenue
- CRMD $43,472,170.00
- GLAD $95,360,000.00
- Revenue This Year
- CRMD $204.98
- GLAD N/A
- Revenue Next Year
- CRMD $22.54
- GLAD $10.81
- P/E Ratio
- CRMD N/A
- GLAD $5.96
- Revenue Growth
- CRMD N/A
- GLAD 5.53
- 52 Week Low
- CRMD $3.61
- GLAD $19.20
- 52 Week High
- CRMD $13.85
- GLAD $30.43
- Technical
- Relative Strength Index (RSI)
- CRMD 22.86
- GLAD 48.52
- Support Level
- CRMD $6.92
- GLAD $26.70
- Resistance Level
- CRMD $11.32
- GLAD $27.99
- Average True Range (ATR)
- CRMD 0.65
- GLAD 0.48
- MACD
- CRMD -0.48
- GLAD 0.09
- Stochastic Oscillator
- CRMD 2.27
- GLAD 78.88
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.